PP_1170x120_10-25-21

prescription drug spending

Rising rebates squeeze branded drug makers

Rising rebates squeeze branded drug makers

WASHINGTON — Branded drug manufacturers are shelling out higher rebates and discounts on medications and seeing their share of prescription drug sales shrink, according to a study commissioned by the Pharmaceutical Research and Manufacturers of America (PhRMA). PhRMA said Wednesday that the study, conducted by Berkeley Research Group (BRG), is among the first to gauge

PhRMA places Rx costs into context

PhRMA places Rx costs into context

The updated “Prescription Medicines: Costs In Context” report from the Pharmaceutical Research and Manufacturers of America (PhRMA) gives both a surprising and not-so-suprising snapshot of the changing Rx marketplace and how the nation’s health system is adapting. More than 7,000 medications are in development worldwide, led by drugs for cancer (1,813), neurological disorders (1,329), infectious

Balancing drug cost vs. access a challenge

Balancing drug cost vs. access a challenge

PARSIPPANY, N.J. — Growth in spending on medicines dipped last year, but that hasn’t eased the challenge of balancing access to drugs and the cost of care in an era of innovative but more expensive treatments, according to the IMS Institute for Healthcare Informatics. For the second year, medication spending climbed by double digits in